PropertyValue
?:definition
  • A proprietary vaccine adjuvant composed of the inorganic compound aluminum phosphate mixed with 3-deacylated monophosphoryl lipid A, a derivate of the bacterial endotoxin. The aluminum component of this adjuvant binds to the protein conjugate, resulting in improved antigenicity, whereas the modified lipid A component enhances the immune responses by activating monocytes, macrophages and cytokines. Combined with vaccine antigens, AS04 adjuvant may help to boost the host\'s immune responses.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C1706672_NCI>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C1706672_NCI>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all